Docket #: S23-057
Hydrogel injection for intestinal lengthening
Stanford scientists have developed a novel approach to help patients with short bowel syndrome by using intestinal lengthening. The solution involves injecting a degradable hydrogel into the intestinal wall to narrow the lumen and enable the confinement of a coiled spring. Currently, no devices are available for deploying inside the intestine to achieve this and existing methods necessitate surgical procedures to anchor the intestinal expanding device. However, as an injectable hydrogel, the solution facilitates endoscopic delivery of the coiled spring into the gastrointestinal tract. While the hydrogel solution enables strategically deploying devices within the gastrointestinal lumen for a transient duration, this approach may also be employed for drugs intended for a particular section of the gastrointestinal tract, anchoring the device near the area of interest instead of opting for systemic delivery.
Applications
- Minimally-invasive method for anchoring intestinal lengthening device (short bowel syndrome)
- Targeted drug delivery in the gastrointestinal tract
Advantages
- Lower need for surgical intervention
- Lower costs required for device placement
- Quicker recovery time
Related Links
Similar Technologies
-
A suprachoroidal spacer implant to treat glaucoma S23-174A suprachoroidal spacer implant to treat glaucoma
-
Dynamic Recombinant Hydrogels with Degradation-Independent Relaxation Kinetics S22-180Dynamic Recombinant Hydrogels with Degradation-Independent Relaxation Kinetics
-
Hetero-assembling, tunable, and injectable hydrogels for cell encapsulation S08-065AHetero-assembling, tunable, and injectable hydrogels for cell encapsulation